Publications by authors named "Putkonen Mervi"

Claim this Profile
E
Evolution of treatment practices and outcomes in multiple myeloma during 2013-2022: a Finnish real world registry study.
Anu Partanen, Marika Waltari, Johanna Vikkula, Riikka Mattila, Katja Närhi, Mervi Putkonen

Acta Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world study on the impact of infection load on mortality in multiple myeloma patients in Finland.
Anna Anttalainen, Essi Havula, Kai Kysenius, Iiro Toppila, Tatu Miettinen, Mervi Putkonen

Ann Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021.
Kai Kysenius, Anna Anttalainen, Iiro Toppila, Tatu Miettinen, Mariann Lassenius, Mervi Putkonen

Ann Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021.
Kai Kysenius, Anna Anttalainen, Iiro Toppila, Tatu Miettinen, Mariann Lassenius, Mervi Putkonen

Ann Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent trends in incidence, survival and treatment of multiple myeloma in Finland - a nationwide cohort study.
Jarno Ruotsalainen, Leena Lehmus, Mervi Putkonen, Juha Lievonen, Alvar Kallio

Ann Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.
Anu Partanen, Anders Waage, Valdas Peceliunas, Fredrik Schjesvold, Pekka Anttila, Mervi Putkonen

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.
Agnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, Rebecca Schultze-Florey, Lilia Goudeva, Mervi Putkonen

J Clin Invest· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the number of cryopreserved CD34 cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study.
Anu Partanen, Antti Turunen, Raija Silvennoinen, Jaakko Valtola, Marja Pyörälä, Mervi Putkonen

J Clin Apher· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of CD34 cell mobilization, blood graft cellular composition, and post-transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low-dose cyclophosphamide: A prospective multicenter study.
Partanen Anu, Turunen Antti, Silvennoinen Raija, Pyörälä Marja, Valtola Jaakko, Putkonen Mervi

Transfusion· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.
Antti Turunen, Raija Silvennoinen, Anu Partanen, Jaakko Valtola, Timo Siitonen, Mervi Putkonen

Transfusion· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD.
Kati Hyvärinen, Satu Koskela, Riitta Niittyvuopio, Anne Nihtinen, Liisa Volin, Mervi Putkonen

Front Immunol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT.
Jarmo Ritari, Kati Hyvärinen, Satu Koskela, Riitta Niittyvuopio, Anne Nihtinen, Mervi Putkonen

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA study.
Antti Turunen, Anu Partanen, Jaakko Valtola, Antti Ropponen, Timo Siitonen, Mervi Putkonen

Transfusion· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group.
Sini Luoma, Pekka Anttila, Marjaana Säily, Tuija Lundan, Jouni Heiskanen, Mervi Putkonen

Ann Hematol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013.
Kari Remes, Pekka Anttila, Raija Silvennoinen, Mervi Putkonen, Hanna Ollikainen

PLoS One· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased MHC Matching by C4 Gene Compatibility in Unrelated Donor Hematopoietic Stem Cell Transplantation.
Jonna Clancy, Jarmo Ritari, Muriel Lobier, Riitta Niittyvuopio, Urpu Salmenniemi, Mervi Putkonen

Biol Blood Marrow Transplant· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT.
Juha Ranti, Samu Kurki, Urpu Salmenniemi, Mervi Putkonen, Soile Salomäki

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study.
Jaakko Valtola, Raija Silvennoinen, Antti Ropponen, Timo Siitonen, Marjaana Säily, Mervi Putkonen

Leuk Lymphoma· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of adult acute myeloid leukemia.
Joni Järvenpää, Maija Itälä-Remes, Tommi Kauko, Urpu Salmenniemi, Marjut Kauppila, Mervi Putkonen

Duodecim· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lenalidomide-based induction therapy on the mobilization of CD34 cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.
Anu Partanen, Jaakko Valtola, Raija Silvennoinen, Antti Ropponen, Timo Siitonen, Mervi Putkonen

Transfusion· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML.
Ulla Impola, Antti Larjo, Urpu Salmenniemi, Mervi Putkonen, Maija Itälä-Remes

Front Immunol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost analysis of a randomized stem cell mobilization study in multiple myeloma.
Ville Varmavuo, Raija Silvennoinen, Pekka Anttila, Marjaana Säily, Marja Sankelo, Mervi Putkonen

Ann Hematol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.
Jaakko Valtola, Raija Silvennoinen, Antti Ropponen, Timo Siitonen, Marjaana Säily, Mervi Putkonen

Transfusion· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Adult acute lymphoblastic leukemia - 20-year treatment results at TYKS].
Rami Nylund, Maija Itälä-Remes, Tommi Kauko, Marjut Kauppila, Mervi Putkonen

Duodecim· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.
Raija Silvennoinen, Veli Kairisto, Tarja-Terttu Pelliniemi, Mervi Putkonen, Pekka Anttila

Br J Haematol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis